Treatment Selection According to Skin Reaction to Cetuximab

NCT01472653 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: cisplatin
RADIATION: radiotherapy
DRUG: cetuximab

Sponsor

Institute of Oncology Ljubljana